logo-loader
viewEMMAC Life Sciences

EMMAC Life Sciences expanding on its medical cannabis acquisitions in London, Portugal, and Spain

EMMAC Life Sciences CEO Antonio Costanzo sat down with Proactive at the Cannabis Europa: Transatlantic Forum in Toronto. 

The London, UK-based medical cannabis company has raised a total of £34 in the past year. It has cultivation operations in Portugal, with extraction and distribution in Spain and in the UK.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Amundi Physical Gold ETC: Europe's cheapest ETC now trading on the London...

Amundi Physical Gold ETC's Ashley Fagan who's head of ETF, Indexing & Smart Beta Development for UK and Ireland introduces the product to Proactive London's Andrew Scott. She says they've seen a great deal of demand from European as well as UK investors and that's what lead them to list...

2 days, 8 hours ago

2 min read